Barclays Believes Mallinckrodt plc (MNK) Divestiture Could Be Prelude for Opiod Settlement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Mallinckrodt (MNK) Extends Gains; Shares Surge 72%
September 10, 2019 1:43 PM EDTMallinckrodt (NYSE: MNK) extends gains. Now up 72.4% on volume that is running 8x the norm.
... MoreMallinckrodt (MNK) Adds to Gains on Divestiture
September 10, 2019 10:20 AM EDTMallinckrodt (NYSE: MNK) adds to early gains following divestiture. Shares are up 47%. Last week, reports had the company going bankrupt.
... MoreMallinckrodt (MNK) Reports Sale of BioVectra Inc. to H.I.G. Capital for $250M
September 10, 2019 6:46 AM EDTMallinckrodt plc (NYSE: MNK) today announced it has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra Inc. to an affiliate of H.I.G. Capital, a leading global private equity investment firm, for approximately $250 million, including fixed consideration of $175 million, comprised of an upfront payment of $135 million and a long-term note for $40 million, and contingent payments of up to $75 million, enabling Mallinckrodt to... More
